MedNation AG (FRA:EIF)
Germany flag Germany · Delayed Price · Currency is EUR
3.800
-0.400 (-9.52%)
Last updated: May 25, 2026, 5:20 PM CET

MedNation AG Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
52.7748.7645.3337.5535.8
Other Revenue
3.58--1.050.89
56.3548.7645.3338.5936.69
Revenue Growth (YoY)
15.56%7.56%17.46%5.18%0.88%
Cost of Revenue
38.6237.7333.9431.3529.77
Gross Profit
17.7311.0311.47.256.93
Selling, General & Admin
-3.4840.550.22
Other Operating Expenses
12.645.335.083.623.12
Operating Expenses
14.0510.1110.247.587.71
Operating Income
3.680.921.15-0.33-0.79
Interest Expense
-0.6-0.73-0.78-3.01-2.9
Interest & Investment Income
-0.03000
Other Non Operating Income (Expenses)
0.040.280.43-0
EBT Excluding Unusual Items
3.110.50.81-3.34-3.68
Gain (Loss) on Sale of Assets
--0.03-0.01--
Asset Writedown
-----3.63
Other Unusual Items
---1.63.21
Pretax Income
3.110.480.82-1.72-4.1
Income Tax Expense
0.350.240.270.120.12
Earnings From Continuing Operations
2.760.230.55-1.85-4.22
Minority Interest in Earnings
-0.24-0.13-0.07-0.04-0.18
Net Income
2.510.10.48-1.89-4.4
Net Income to Common
2.510.10.48-1.89-4.4
Net Income Growth
2300.69%-78.25%---
Shares Outstanding (Basic)
23333
Shares Outstanding (Diluted)
23333
Shares Change (YoY)
-16.37%-6.94%---
EPS (Basic)
1.070.040.16-0.63-1.46
EPS (Diluted)
1.070.040.16-0.63-1.46
EPS Growth
2770.79%-76.63%---
Free Cash Flow
0.881.450.640.322.68
Free Cash Flow Per Share
0.380.520.210.100.89
Gross Margin
31.46%22.62%25.14%18.78%18.87%
Operating Margin
6.52%1.88%2.54%-0.86%-2.14%
Profit Margin
4.46%0.21%1.06%-4.89%-11.99%
Free Cash Flow Margin
1.57%2.97%1.41%0.82%7.29%
EBITDA
5.092.232.320.931.09
EBITDA Margin
9.04%4.58%5.11%2.41%2.96%
D&A For EBITDA
1.421.311.171.261.87
EBIT
3.680.921.15-0.33-0.79
EBIT Margin
6.52%1.88%2.54%-0.86%-2.14%
Effective Tax Rate
11.37%51.12%32.87%--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.